# Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies and Federal Facilities Guidance for Industry - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/compounding-and-repackaging-of-radiopharmaceuticals-by-state-licensed-nuclear-pharmacies-and-federal-facilities-guidance-for-industry/2b25a2e1-6aae-4b9c-a16b-579918ea3410 > FDA guidance document: Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies and Federal Facilities Guidance for Industry. Issue date: September 26, 2018. Get complete insights and analysis. --- ## Details - Title: Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies and Federal Facilities Guidance for Industry - Communication Type: Guidance Document - Product Type: drugs - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2018-09-26 - Last Changed: 2020-05-07 - Docket Number: FDA-2016-D-4318 ## Related Documents - [Compounding and Repackaging of Radiopharmaceuticals By Outsourcing Facilities Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/compounding-and-repackaging-of-radiopharmaceuticals-by-outsourcing-facilities-guidance-for-industry/4a6e41fb-5d18-47fc-98b0-1dbe619a89b6) - [Facility Definition Under Section 503B of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/facility-definition-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/0757072b-35f4-40f5-97ac-c401faa17cb3) - [Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/adverse-event-reporting-for-outsourcing-facilities-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/4c23f98f-eaf3-4ed1-8f57-33ea6ba03529)